BioMaxima Statistics

Total Valuation

BioMaxima has a market cap or net worth of PLN 61.85 million. The enterprise value is 73.92 million.

Market Cap	61.85M
Enterprise Value	73.92M

Important Dates

The last earnings date was Wednesday, September 18, 2024.

Earnings Date	Sep 18, 2024
Ex-Dividend Date	n/a

Share Statistics

BioMaxima has 4.19 million shares outstanding. The number of shares has decreased by -3.64% in one year.

Shares Outstanding	4.19M
Shares Change (YoY)	-3.64%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	30.56%
Owned by Institutions (%)	n/a
Float	2.35M

Valuation Ratios

The trailing PE ratio is 174.67.

PE Ratio	174.67
Forward PE	n/a
PS Ratio	1.33
PB Ratio	1.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.77, with an EV/FCF ratio of -6.62.

EV / Earnings	204.77
EV / Sales	1.56
EV / EBITDA	27.77
EV / EBIT	n/a
EV / FCF	-6.62

Financial Position

The company has a current ratio of 2.28, with a Debt / Equity ratio of 27.22.

Current Ratio	2.28
Quick Ratio	1.06
Debt / Equity	27.22
Debt / EBITDA	4.81
Debt / FCF	-1.15
Interest Coverage	-0.04

Financial Efficiency

Return on equity (ROE) is 0.72% and return on invested capital (ROIC) is -0.03%.

Return on Equity (ROE)	0.72%
Return on Assets (ROA)	-0.03%
Return on Capital (ROIC)	-0.03%
Revenue Per Employee	410,800
Profits Per Employee	3,139
Employee Count	115
Asset Turnover	0.65
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.38% in the last 52 weeks. The beta is -2.42, so BioMaxima's price volatility has been lower than the market average.

Beta (5Y)	-2.42
52-Week Price Change	-21.38%
50-Day Moving Average	16.54
200-Day Moving Average	15.52
Relative Strength Index (RSI)	40.14
Average Volume (20 Days)	5,042

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioMaxima had revenue of PLN 47.24 million and earned 361,000 in profits. Earnings per share was 0.08.

Revenue	47.24M
Gross Profit	22.31M
Operating Income	-31,000
Pretax Income	-60,000
Net Income	361,000
EBITDA	2.51M
EBIT	-31,000
Earnings Per Share (EPS)	0.08

Full Income Statement

Balance Sheet

The company has 729,000 in cash and 12.80 million in debt, giving a net cash position of -12.07 million or -2.88 per share.

Cash & Cash Equivalents	729,000
Total Debt	12.80M
Net Cash	-12.07M
Net Cash Per Share	-2.88
Equity (Book Value)	47.03M
Book Value Per Share	11.22
Working Capital	13.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.00 million and capital expenditures -16.17 million, giving a free cash flow of -11.16 million.

Operating Cash Flow	5.00M
Capital Expenditures	-16.17M
Free Cash Flow	-11.16M
FCF Per Share	-2.66

Full Cash Flow Statement

Margins

Gross margin is 47.23%, with operating and profit margins of -0.07% and 0.76%.

Gross Margin	47.23%
Operating Margin	-0.07%
Pretax Margin	-0.13%
Profit Margin	0.76%
EBITDA Margin	5.32%
EBIT Margin	-0.07%
FCF Margin	-23.63%

Dividends & Yields

This stock pays an annual dividend of 0.39, which amounts to a dividend yield of 2.64%.

Dividend Per Share	0.39
Dividend Yield	2.64%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	580.89%
Buyback Yield	3.64%
Shareholder Yield	6.28%
Earnings Yield	0.57%
FCF Yield	-18.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioMaxima has an Altman Z-Score of 3.23.

Altman Z-Score	3.23
Piotroski F-Score	n/a